Sevelamer treatment for hyperphosphatemia in dialysis patients may provide benefits in addition to lowering phosphorus, according to a study conducted in Taiwan that was presented at ASN’s Renal ...

Sevelamer did not appear to reduce the risk for death from causes other than CV, so all of its beneficial effect on all-cause mortality risk appeared to come from its effect on CV mortality.

Find all the commercial and brand names of generic drug called Sevelamer. This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need of ...

Patients who received calcium-containing binders had a threefold higher death risk than those who received sevelamer, Dr. Block’s group reported in Kidney International (2007;71:438-441).

Philadelphia, PA - Results of the Dialysis Clinical Outcomes Revisited (DCOR) trial showed a nonsignificant 9% reduction in all-cause mortality for patients treated with sevelamer hydrochloride ...

Objective: Sevelamer hydrochloride is a phosphate binder used to treat hyperphosphatemia in chronic kidney disease (CKD) patients that can reduce valvular and vascular calcification. The aim of this ...